Clinical Trials on Vin II
Total 10771 results
-
Carl T. Hayden VA Medical CenterSanofiCompletedDiabetes Mellitus, Type IIUnited States
-
AstraZenecaCompletedType II Diabetes MellitusSweden, Mexico, Peru, United Kingdom, Germany, Hungary, Latvia, Lithuania, Poland, Chile, Romania
-
East Carolina UniversityCompletedDiabetes Mellitus Type IIUnited States
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, India, Romania, Germany, Lithuania
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
GenfitCompletedType II Diabetes MellitusBosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
-
PfizerCompletedDiabetes Mellitus, Type IIBelgium
-
Center for Integrative Medicine, GermanyUnknownDiabetes Mellitus, Type IIGermany
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
ECbiotech TaiwanCompletedThe Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)Diabetes Mellitus, Type IITaiwan
-
Aristotle University Of ThessalonikiUniversity of AthensCompletedType II Diabetes MellitusGreece
-
University of Texas at AustinWashington University School of Medicine; Ohio State UniversityCompletedStage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Ductal Carcinoma in Situ | Lobular Breast Carcinoma | Stage III Breast Cancer | Ductal Breast CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedDepression | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Anxiety Disorder | Psychosocial Effects of Cancer and Its Treatment | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in SituUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II Pompe DiseaseUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type II-Pompe's DiseaseUnited States, France, Japan, Taiwan, United Kingdom
-
National Cancer Institute (NCI)CompletedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell LymphomaUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)SuspendedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor Positive Breast Carcinoma | Breast Ductal Carcinoma in Situ | HER2 Negative Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Ductal Breast Carcinoma In Situ | Stage I Breast Cancer AJCC v6United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedDepression | Fatigue | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Anxiety Disorder | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
Affiliated Hospital of Jiangnan UniversityRecruitingPositron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor EfficacySolid Tumor | Breast Cancer Stage II | Breast Cancer Stage IIIChina
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
MarsiBionicsHospital Universitario La PazCompletedCerebral Palsy | Neuromuscular Diseases | SMA IISpain
-
Mountain Diabetes and Endocrine CenterCompletedDiabetes Mellitus, Type IIUnited States
-
ClinisionCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IVPakistan
-
Getz PharmaCompletedType II Diabetes MellitusPakistan
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType II Diabetes MellitusUnited States
-
Materia Medica HoldingCompletedType II Diabetes MellitusRussian Federation
-
Joslin Diabetes CenterMassachusetts Institute of TechnologyCompletedType II DiabetesUnited States
-
TakedaCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
University of BolognaCompletedSiewert Type II Adenocarcinoma of Esophagogastric JunctionItaly
-
Yonsei UniversityCompleted
-
Hua Medicine LimitedCompletedType II Diabetes MellitusChina
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
PfizerCompletedDiabetes Mellitus, Type IIUnited States
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research InstituteUnknownMeasuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingType II DiabetesUnited States
-
Medical University of ViennaCompletedDiabetes Mellitus Type IIAustria
-
BayerCompleted
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States